HighTower Advisors’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.48M Sell
112,983
-52,643
-32% -$1.62M ﹤0.01% 1467
2026
Q2
$4.72M Buy
165,626
+128,948
+352% +$2.78M ﹤0.01% 1279
2026
Q1
$421K Sell
36,678
-17,476
-32% -$246K ﹤0.01% 2870
2025
Q4
$778K Sell
54,154
-8,666
-14% -$150K ﹤0.01% 2298
2025
Q3
$1.19M Buy
+62,820
New +$1.04M ﹤0.01% 1980
2024
Q4
– Sell
-28,584
Closed -$600K – 3997
2024
Q3
$600K Buy
28,584
+18,038
+171% +$325K ﹤0.01% 2270
2024
Q2
$159K Buy
+10,546
New +$194K ﹤0.01% 3089

Other funds holding OSCR

HighTower Advisors's OSCR Position: Q3 2026 in Review

HighTower Advisors reduced its Oscar Health (OSCR) stake by 32% in Q3 2026, selling an estimated $1.62M and leaving 112,983 shares worth $3.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1467.

HighTower Advisors first reported a position in OSCR in Q2 2024 and has held it in 7 quarters since. The position peaked at $4.72M in Q2 2026. 320 funds tracked by Wall St. Rank hold OSCR as of Q3 2026.

  • HighTower Advisors held 112,983 shares of Oscar Health worth $3.48M as of Q3 2026.
  • HighTower Advisors sold 52,643 Oscar Health shares in Q3 2026, an estimated $1.62M.
  • Oscar Health made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #1467 holding.
  • HighTower Advisors first reported a position in Oscar Health in Q2 2024 and has held it in 7 quarters since.
  • HighTower Advisors's Oscar Health position peaked at $4.72M in Q2 2026.
  • 320 funds tracked by Wall St. Rank held Oscar Health as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.